Education
About Us
Working with TipRanks
Follow Us
EKF Diagnostics Holdings PLC (GB:EKF)
LSE:EKF
Earnings Data
Report Date
Mar 31, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
<0.01Last Year’s EPS
<0.01Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with notable revenue and profit growth, increased production capacity, and successful new contracts. However, there were challenges in the APAC region and some market constraints affecting the share buyback program. Overall, the positives, including significant production increases and strategic growth plans, outweigh the negatives.Company Guidance
Revenue and Profit Growth
Revenues for the first half were GBP 25.2 million, in line with the previous year, but closer to GBP 26 million on a constant currency basis. Gross profit improved with a gross margin increase to 50% from 48%. EBITDA grew by 7.4% to GBP 5.8 million, and profit increased by 16.1%.
Increase in Production and New Contracts
Hematology analyzer production increased by 60% compared to the previous year. Three new contracts were signed in strategic growth areas, specifically in Africa and Latin America.
Beta-Hydroxybutyrate Performance
Sales of Beta-Hydroxybutyrate increased by 12%, or 16% on a consistent currency basis, reflecting strong performance.
Share Buyback Program
The company implemented a share buyback program, acquiring 4.6 million shares, aimed at improving earnings per share.
Hematology Analyzer Growth
Significant growth in hematology analyzer build at 125%, with major deployments in Peru, Brazil, USA, and Italy.
Pipeline and New Business in Life Sciences
A $1.5 million pipeline of new business in Life Sciences, with a significant contract in the final stages of agreement.
GB:EKF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:EKF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Sep 16, 2025 | 29.00p | 29.90p | +3.10% |
Mar 25, 2025 | 20.50p | 23.25p | +13.41% |
Sep 17, 2024 | 27.50p | 27.25p | -0.91% |
Mar 20, 2024 | 26.65p | 23.60p | -11.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does EKF Diagnostics Holdings PLC (GB:EKF) report earnings?
EKF Diagnostics Holdings PLC (GB:EKF) is schdueled to report earning on Mar 31, 2026, TBA (Confirmed).
What is EKF Diagnostics Holdings PLC (GB:EKF) earnings time?
EKF Diagnostics Holdings PLC (GB:EKF) earnings time is at Mar 31, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of EKF Diagnostics Holdings PLC stock?
The P/E ratio of EKF Diagnostics Holdings is N/A.
What is GB:EKF EPS forecast?
GB:EKF EPS forecast for the fiscal quarter 2025 (Q4) is <0.01.